Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-21-039168)

Filing Details

Accession Number:: 0001213900-21-039168
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-07-28 21:46:08
Reporting Period:: 2021-07-26

Accepted Time:: 2021-07-28 21:46:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1739174	Biomx Inc.	PHGE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1761120	Gbolahan Amusa	C/O Chardan Capital Markets Llc 17 State Street, 21 Floor New York NY 10004		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Acquisiton	2021-07-26	25,000	$0.00	262,871	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants to purchase Common Stock	Acquisiton	2021-07-26	18,750	$0.00	18,750	$5.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,750	2022-10-28	2027-01-28	No	4	P	Direct

Footnotes

The reporting person acquired 25,000 units consisting of one share of common stock and three-quarters of one warrant at a purchase price of $4.00 per unit.